Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:02 PM
Ignite Modification Date:
2025-12-24 @ 3:02 PM
NCT ID:
NCT03489759
Eligibility Criteria:
Inclusion Criteria:
* Age \> 18 years
* Acute Kidney Injury
* ICU patients with clinical indication for Continuous Renal Replacement Therapy
* Clinical decision to begin CVVH for at least 24 hours with high flux filter (defined as membranes with an ultrafiltration coefficient KUF \> 25ml/Kg/h)
* Obtain the informed consent
Exclusion Criteria:
* Hemodialysis patients, peritoneal dialysis patients and transplant recipient;
* Hypothermia (T \< 36°C)
* Regional Anticoagulation with Citrate
* Septic Shock;
* Neoplasm in Chemotherapy
* Extra-Corporeal Membrane Oxygenation
* Cardio Circulatory Arrest
* Autoimmune disease or immunosuppressed patients;
* Life expectancy \< 24 hr
* Pregnancy;
* Informed Consent refused by the patient or surrogate decision-maker
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03489759
Study Brief:
Protocol Section:
NCT03489759